STOCK TITAN
  1. Home
  2. Sec-filings
  3. RVMD
  4. [Form 4] Revolution Medicines, Inc. Insider Trading Activity

Revolution Medicines (RVMD) director granted RSUs and stock options in latest Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Revolution Medicines director Elizabeth M. Anderson reported compensation-related equity grants and updated holdings. She received 1,191 shares of common stock as a grant of restricted stock units and a stock option for 3,127 shares at an exercise price of $162.99 per share.

The option covers 3,127 shares of common stock and expires on June 18, 2036. These option shares vest in full on the earlier of the first anniversary of June 18, 2026 or immediately before the next Annual Meeting after the grant date, assuming she continues as a service provider.

After these awards, Anderson directly holds 9,406 shares of common stock, which include the 1,191 restricted stock units. Separately, 26,990 shares of common stock are held indirectly through the David W. Anderson 1996 Irrevocable Trust.

Positive

  • None.

Negative

  • None.
Insider ANDERSON ELIZABETH M
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 3,127 $0.00 --
Grant/Award Common Stock 1,191 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 3,127 shares (Direct, null); Common Stock — 9,406 shares (Direct, null); Common Stock — 26,990 shares (Indirect, See footnote)
Footnotes (1)
  1. Includes 1,191 restricted stock units. Held by David W. Anderson 1996 Irrevocable Trust. Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 18, 2026 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
RSU grant 1,191 shares Restricted stock units granted to director
Option grant size 3,127 shares Stock Option (Right to Buy) underlying common shares
Option exercise price $162.99 per share Conversion or exercise price for stock option
Option expiration June 18, 2036 Expiration date of stock option grant
Direct common shares after grant 9,406 shares Total common stock directly held after transactions
Indirect trust-held shares 26,990 shares Common stock held by David W. Anderson 1996 Irrevocable Trust
restricted stock units financial
"Includes 1,191 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy financial
"security_title: "Stock Option (Right to Buy)""
indirect ownership financial
"direct_or_indirect: "I", ownership_type: "indirect""
Annual Meeting financial
"immediately prior to the Annual Meeting following the date of grant"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
service provider financial
"subject to the Reporting Person remaining a Service Provider"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ANDERSON ELIZABETH M
(Last)(First)(Middle)
C/O REVOLUTION MEDICINES, INC.
700 SAGINAW DRIVE
(Street)
REDWOOD CITY CALIFORNIA 94063
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Revolution Medicines, Inc. [ RVMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/18/2026A1,191A$09,406(1)D
Common Stock26,990ISee footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$162.9906/18/2026A3,127 (3)06/18/2036Common Stock3,127$03,127D
Explanation of Responses:
1. Includes 1,191 restricted stock units.
2. Held by David W. Anderson 1996 Irrevocable Trust.
3. Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 18, 2026 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date.
/s/ Jack Anders, as Attorney-in-fact for Elizabeth M. Anderson06/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did Elizabeth M. Anderson receive in this RVMD Form 4 filing?

Elizabeth M. Anderson received a grant of 1,191 restricted stock units and a stock option for 3,127 shares of Revolution Medicines common stock at an exercise price of $162.99 per share as part of her director compensation.

How many Revolution Medicines (RVMD) shares does Elizabeth M. Anderson hold after this Form 4?

After these grants, Elizabeth M. Anderson directly holds 9,406 shares of Revolution Medicines common stock, including the 1,191 restricted stock units. An additional 26,990 shares are held indirectly through the David W. Anderson 1996 Irrevocable Trust.

What are the vesting terms of Elizabeth M. Anderson’s new RVMD stock option?

The new stock option for 3,127 shares of Revolution Medicines common stock vests in full on the earlier of the first anniversary of June 18, 2026 or immediately before the next Annual Meeting, assuming she continues as a service provider.

What is the exercise price and expiration date of Anderson’s RVMD stock option grant?

The stock option granted to Elizabeth M. Anderson has an exercise price of $162.99 per share and covers 3,127 shares. The option expires on June 18, 2036, providing a long-dated right to purchase Revolution Medicines common stock.

How are the indirect RVMD shares held for Elizabeth M. Anderson structured?

The filing shows 26,990 shares of Revolution Medicines common stock held indirectly through the David W. Anderson 1996 Irrevocable Trust. This indicates a trust structure rather than direct personal ownership for that portion of her reported holdings.